Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-24An Open Label Optimization Study to Assess the Effectiveness of the SAINT® Neuromodulation System (NMS) to Treat Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-12-23An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
-
CLINICAL_TRIALS study record update · 2025-12-22Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients
-
CLINICAL_TRIALS study record update · 2025-12-22Will Work for Reward: Effects of Ghrelin Administration on Dopamine and Effort
-
CLINICAL_TRIALS study record update · 2025-12-22The Effects of Ghrelin Administration on Motivation and Resting Energy Expenditure
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-17Beyond the Clinic: Enhancing Depression Surveillance With a Digital Biomarker
-
CLINICAL_TRIALS study record update · 2025-12-16Osteopathic Manipulative Treatment as an Adjunctive Treatment in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-12-16An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities
-
CLINICAL_TRIALS study record update · 2025-12-16A Two-Part Controlled Clinical Study to Evaluate Safety, Tolerability, Response, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Doses of GM-1020 in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-12-12Psilocybin-assisted Cognitive Behavioral Therapy for Depression
-
CLINICAL_TRIALS study record update · 2025-12-12PREDICT: Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
-
CLINICAL_TRIALS study record update · 2025-12-12A Randomized Controlled Trial Comparing Propofol and Ketofol for Hemodynamic Stability During Electroconvulsive Therapy
-
CLINICAL_TRIALS study record update · 2025-12-12Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
-
CLINICAL_TRIALS study record update · 2025-12-12Mechanism of Action of Transcranial Magnetic Stimulation
-
CLINICAL_TRIALS study record update · 2025-12-10Effectiveness of Metacognitive Training on Symptoms and Cognitive Biases in Taiwanese Individuals With Mental Disorders: A One-Group Pretest-Posttest Study
-
CLINICAL_TRIALS study record update · 2025-12-10Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Double-Blind Trial
-
CLINICAL_TRIALS study record update · 2025-12-08Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders.
-
CLINICAL_TRIALS study record update · 2025-12-05Integrated Internet-Based Cognitive Behavioural Therapy (i-CBT) and Intravenous Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-12-04D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression: A Multi-Site, Randomised, Placebo-Controlled Trial (COGENT)
-
CLINICAL_TRIALS study record update · 2025-12-03A Pilot, Phase II, Open-Label, Single-Center Study of Sodium-Glucose Cotransporter-2 Inhibitor Empagliflozin in Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-12-01A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2025-11-28Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)
-
CLINICAL_TRIALS study record update · 2025-11-28Investigating Mechanisms of Change in Supportive-Expressive vs. Emotion-Focused Treatment of Depression Using a Personalized Treatment Approach: The Case of the Theories of Weakness vs. Strength
-
CLINICAL_TRIALS study record update · 2025-11-26A Phase 3, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2025-11-26Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder